- Home
- DAVEW vs LSB Comparison
DAVEW vs LSB Comparison
Compare DAVEW & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAVEW
- LSB
- Stock Information
- Founded
- DAVEW 2015
- LSB 2002
- Country
- DAVEW United States
- LSB China
- Employees
- DAVEW 274
- LSB N/A
- Industry
- DAVEW Retail: Computer Software & Peripheral Equipment
- LSB
- Sector
- DAVEW Technology
- LSB
- Exchange
- DAVEW Nasdaq
- LSB NYSE
- Market Cap
- DAVEW N/A
- LSB 22.3M
- IPO Year
- DAVEW N/A
- LSB N/A
- Fundamental
- Price
- DAVEW $2.04
- LSB $1.02
- Analyst Decision
- DAVEW
- LSB
- Analyst Count
- DAVEW 0
- LSB 0
- Target Price
- DAVEW N/A
- LSB N/A
- AVG Volume (30 Days)
- DAVEW 46.1K
- LSB 24.5K
- Earning Date
- DAVEW 03-06-2025
- LSB 07-07-2025
- Dividend Yield
- DAVEW N/A
- LSB N/A
- EPS Growth
- DAVEW N/A
- LSB N/A
- EPS
- DAVEW 3.12
- LSB N/A
- Revenue
- DAVEW $319,355,000.00
- LSB $79,415,311.00
- Revenue This Year
- DAVEW N/A
- LSB $39.33
- Revenue Next Year
- DAVEW N/A
- LSB $75.61
- P/E Ratio
- DAVEW $34.00
- LSB N/A
- Revenue Growth
- DAVEW 30.00
- LSB N/A
- 52 Week Low
- DAVEW $0.28
- LSB $0.36
- 52 Week High
- DAVEW $0.32
- LSB $6.82
- Technical
- Relative Strength Index (RSI)
- DAVEW N/A
- LSB 48.50
- Support Level
- DAVEW N/A
- LSB $0.89
- Resistance Level
- DAVEW N/A
- LSB $1.12
- Average True Range (ATR)
- DAVEW 0.00
- LSB 0.06
- MACD
- DAVEW 0.00
- LSB 0.02
- Stochastic Oscillator
- DAVEW 0.00
- LSB 56.52
About DAVEW Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.